BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30352099)

  • 1. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
    Farr K; Ravindran R; Strnad L; Chang E; Chaisson LH; Yoon C; Worodria W; Andama A; Ayakaka I; Bbosa Nalwanga P; Byanyima P; Kalema N; Kaswabuli S; Katagira W; Aman KD; Musisi E; Tumwine NW; Sanyu I; Ssebunya R; Davis JL; Huang L; Khan IH; Cattamanchi A
    PLoS One; 2018; 13(10):e0206119. PubMed ID: 30352099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda.
    Cox SR; Erisa KC; Kitonsa PJ; Nalutaaya A; Nantale M; Kayondo F; Mukiibi J; Mukiibi M; Nakasolya O; Dowdy DW; Katamba A; Kendall EA
    Ann Am Thorac Soc; 2024 Jun; 21(6):875-883. PubMed ID: 38259069
    [No Abstract]   [Full Text] [Related]  

  • 3. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Yoon C; Semitala FC; Atuhumuza E; Katende J; Mwebe S; Asege L; Armstrong DT; Andama AO; Dowdy DW; Davis JL; Huang L; Kamya M; Cattamanchi A
    Lancet Infect Dis; 2017 Dec; 17(12):1285-1292. PubMed ID: 28847636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.
    Mihret A; Bekele Y; Bobosha K; Kidd M; Aseffa A; Howe R; Walzl G
    J Infect; 2013 Apr; 66(4):357-65. PubMed ID: 23178506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
    Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda.
    Mwebe SZ; Yoon C; Asege L; Nakaye M; Katende J; Andama A; Cattamanchi A; Semitala FC
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115281. PubMed ID: 33453673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.
    Shete PB; Ravindran R; Chang E; Worodria W; Chaisson LH; Andama A; Davis JL; Luciw PA; Huang L; Khan IH; Cattamanchi A
    PLoS One; 2017; 12(8):e0180122. PubMed ID: 28767658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV.
    Queiroz ATL; Araújo-Pereira M; Barreto-Duarte B; Gomes-Silva A; Costa AG; Andrade AMS; Miguez-Pinto JP; Spener-Gomes R; Souza AB; Benjamin A; Sant'Anna F; Figueiredo MC; Mave V; Salgame P; Ellner JJ; Sterling TR; Cordeiro-Dos-Santos M; Andrade BB; Rolla VC
    Front Immunol; 2022; 13():890003. PubMed ID: 35757685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.
    Sivakumaran D; Ritz C; Gjøen JE; Vaz M; Selvam S; Ottenhoff THM; Doherty TM; Jenum S; Grewal HMS
    Front Immunol; 2020; 11():626049. PubMed ID: 33613569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.
    Davis JL; Huang L; Worodria W; Masur H; Cattamanchi A; Huber C; Miller C; Conville PS; Murray P; Kovacs JA
    PLoS One; 2011 Jan; 6(1):e16321. PubMed ID: 21298001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa.
    Rambaran S; Naidoo K; Lewis L; Hassan-Moosa R; Govender D; Samsunder N; Scriba TJ; Padayatchi N; Sivro A
    Front Immunol; 2021; 12():641065. PubMed ID: 33868272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    Shapiro AE; Hong T; Govere S; Thulare H; Moosa MY; Dorasamy A; Wallis CL; Celum CL; Grosset J; Drain PK
    AIDS; 2018 Aug; 32(13):1811-1820. PubMed ID: 29847333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.
    Riou C; Perez Peixoto B; Roberts L; Ronacher K; Walzl G; Manca C; Rustomjee R; Mthiyane T; Fallows D; Gray CM; Kaplan G
    PLoS One; 2012; 7(5):e36886. PubMed ID: 22606304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
    Nakiyingi L; Bwanika JM; Kirenga B; Nakanjako D; Katabira C; Lubega G; Sempa J; Nyesiga B; Albert H; Manabe YC
    PLoS One; 2013; 8(9):e74023. PubMed ID: 24040151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
    Cattamanchi A; Ssewenyana I; Nabatanzi R; Miller CR; Den Boon S; Davis JL; Andama A; Worodria W; Yoo SD; Cao H; Huang L
    PLoS One; 2012; 7(6):e39838. PubMed ID: 22745833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.